Waystar Holding Corp header image

Waystar Holding Corp

WAY

Equity

ISIN null / Valor 130358792

NASDAQ (2025-11-17)
USD 34.29-2.92%

Waystar Holding Corp
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Waystar Holding Corp is a company specializing in healthcare technology solutions, primarily focusing on enhancing operational efficiency for healthcare providers through its advanced software platform. A key component of its offerings is the Waystar Altitude AI™, an artificial intelligence-driven tool designed to automate tasks, prioritize workflows, and minimize errors within healthcare operations. This AI solution is integrated throughout Waystar's platform, aiming to streamline processes and improve outcomes for healthcare organizations. By leveraging technology to address administrative challenges, Waystar supports healthcare providers in optimizing their revenue cycle management and overall operational performance.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results (17.11.2025):

Waystar Holding Corp reported robust financial performance for Q2 2025, ending June 30, 2025, driven by AI-powered innovations and strong client relationships. The company achieved 15% year-over-year revenue growth, with GAAP net income of $32.2 million and non-GAAP net income of $65.7 million, while also raising guidance for fiscal year 2025.

Revenue & Earnings Growth

The company posted Q2 2025 revenue of $270.7 million—a 15% increase year-over-year—underscoring its strong market position. GAAP net income reached $32.2 million with a 12% net income margin, and non-GAAP net income totaled $65.7 million.

Operational Efficiency

Waystar achieved an adjusted EBITDA of $112.6 million with a 42% margin, supported by favorable cash flow performance, including $97 million from operations and $111 million in unlevered free cash flow.

Guidance Upgrade

The company raised its revenue and adjusted EBITDA guidance for 2025 to a range of $1.030 billion to $1.042 billion in revenue and $418 million to $426 million in adjusted EBITDA, reflecting strong momentum and positive market dynamics.

Strategic Initiatives

In addition to solid quarterly results, Waystar announced an agreement to acquire Iodine Software. This move is expected to expand the company's addressable market and enhance its value proposition for healthcare providers.

Summarized from source with an LLMView Source

Key figures

13.2%1Y
%3Y
%5Y

Performance

36.1%1Y
35.3%3Y
35.3%5Y

Volatility

Market cap

6560 M

Market cap (USD)

Daily traded volume (Shares)

1,318,545

Daily traded volume (Shares)

1 day high/low

37.58 / 36.62

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Nelnet Inc
Nelnet Inc Nelnet Inc Valor: 1665235
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-3.17%USD 125.10
Intuitive Surgical Inc
Intuitive Surgical Inc Intuitive Surgical Inc Valor: 1631646
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.51%USD 546.71
Bristol-Myers Squibb Co
Bristol-Myers Squibb Co Bristol-Myers Squibb Co Valor: 914188
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.34%USD 46.82
Getinge AB
Getinge AB Getinge AB Valor: 84926
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.44%SEK 212.20
Camurus AB
Camurus AB Camurus AB Valor: 30510553
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-3.34%SEK 622.00
GSK PLC
GSK PLC GSK PLC Valor: 120042705
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.74%USD 47.53
SOLVENTUM CORP
SOLVENTUM CORP SOLVENTUM CORP Valor: 133635906
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.70%USD 76.19
Sandoz Group Ltd
Sandoz Group Ltd Sandoz Group Ltd Valor: 124359842
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.15%CHF 54.92
Globus Medical Inc
Globus Medical Inc Globus Medical Inc Valor: 18329123
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.96%USD 83.64
Outset Medical Inc
Outset Medical Inc Outset Medical Inc Valor: 56717137
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
5.13%USD 4.92